Consistent with this possibility, it has been shown that restoring expression of a catalytic subunit of PP2A can revert EMT and suppress tumor growth and metastasis in an orthotopic mouse model of human prostate cancer [32]. The gene discussed is PTPA; the disease is prostate carcinoma.